1. December 16, 2008

    Ikonisys to Present at the J.P. Morgan 27th Annual Healthcare Conference

  2. December 9, 2008

    Omeros Announces Results from a Phase 1 Studyof OMS201 for Use During Urological Surgery

  3. November 13, 2008

    Optovue Reaches Milestone with Placement of 1000th RTVue FD-OCT

  4. October 28, 2008

    Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test

  5. October 14, 2008

    Ikonisys Reports Positive Results from Clinical Study Designed to Evaluate the Efficacy of Circulating Tumor Cell Detection with Ikonisys' Automated Microscope

  6. September 24, 2008

    Omeros and BlueCrest Announce $20 Million Debt Facility

  7. September 23, 2008

    Ikonisys to Present at AdvaMed 2008: The MedTech Conference

  8. September 22, 2008

    Ikonisys Introduces Rare-Cell Test Designed to Determine Early Progression to Cervical Cancer

  9. September 22, 2008

    Calypso Medical and Siemens Announce Innovative Product Development Collaboration Agreement

  10. September 22, 2008

    Calypso Medical and The University of Pennsylvania Health System Announce Collaboration for Proton Therapy

  11. September 21, 2008

    Calypso Medical Technologies Reports Advancements in Radiation Treatment for Cancer Patients

  12. September 21, 2008

    Calypso Medical Announces First Post-Operative Prostatectomy Patient Implanted in Clinical Study to Track Tissue Motion during Radiation Therapy

  13. September 21, 2008

    Calypso Medical Technologies, Inc., Announces New Reimbursement Codes for Intrafraction Tracking and Implantable Transponders

  14. September 20, 2008

    Calypso Medical 's Real-Time Tracking Technology in Radiation Therapy Highlighted in 23 Clinical Presentations at the 50th Annual ASTRO Scientific Sessions

  15. September 18, 2008

    Ikonisys Ikonisys to Present at UBS Global Life Sciences Conference